Drug profile · INN
somatrogon-ghla
NGENLA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
somatrogon-ghla (NGENLA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN somatrogon-ghla
Brand NGENLA
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is somatrogon-ghla?
somatrogon-ghla (NGENLA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for somatrogon-ghla?
NGENLA is a marketed brand name for somatrogon-ghla. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of somatrogon-ghla?
somatrogon-ghla has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.